(zoster, vaccine live, attenuated [Oka/Merck], refrigerator-stable)
Shingles has been described as excruciating, intense, potentially debilitating, with nerve pain that can last for months or even years.
The only shingles vaccine that’s given as a single shot.
Learn more about insurance coverage for single‑shot ZOSTAVAX® II
See our resources section for more information on shingles, its causes, who is at risk and vaccination.
If you’ve had chickenpox you’re at risk, and if you’re over 50 you’re at increased risk.
The virus stays in your body and can later become active again as shingles. As you get older, your chance of developing shingles goes up.
Every adult who had chickenpox is at risk of developing shingles
It is estimated that nearly 1 in 3 people will have shingles in their lifetime.
For those who reach age 85, 1 in 2 will have had shingles.
ZOSTAVAX® II is indicated for the prevention of shingles. It cannot be used to treat existing shingles or the pain associated with existing shingles.
Merck Canada does not review or control the content of any non-Merck site. Merck Canada is not associated with this non-Merck website and cannot be held responsible for the accuracy, content, practices or standards of this website and for the consequences of any decision taken on the basis of the content featured on such website.
